April 10, 2024
Open to all ISPOR Members and Non-members
Title: Revolutionizing Clinical Trials: Harnessing Real-World Evidence to Drive Diversity and Clinical Implementation
Wednesday, April 10, 2024
11:00AM EDT | 3:00PM UTC | 5:00PM CEST
Click here for time zone conversion
Register Now
Join us as we explore the ever-changing intersection of real-world evidence (RWE) and clinical trials. In this session, we'll discuss leveraging RWE to enhance diversity within clinical trials and expedite the translation of research findings into real-world clinical practice. Our expert panel will illuminate how RWE can address existing disparities in clinical trial participation, amplify the voices of underrepresented communities, and ultimately lead to more effective and equitable healthcare interventions.
Learning Objectives
- Explore the transformative potential of real-world evidence (RWE) in enhancing clinical trial design and execution.
- Discuss cutting-edge technologies shaping the future of clinical research from Natural Language Processing (NLP) to AI-driven analytics.
- Identify practical strategies for integrating RWE and technology to optimize trial efficiency and outcomes.
Moderator:
Myla Maloney, MBA, BCMAS, Chief Growth Officer, PINC AI Applied Sciences, a Division of Premier, Charlotte, NC, USA
Speakers:
Vani Nilakantan, PhD, System Vice President of Research, CommonSpirit Research Institute, The Colony, TX, USA
Chad Adams, MPH, Associate Vice President of Research, HonorHealth; Chief Operational Officer, HonorHealth Research Institute, Scottsdale, AZ, USA
Anhaita Jamula, CCRC, Director of Research, EvergreenHealth, Kirkland, WA, USA
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.